http://orcid.org/0000-0001-7850-8515
Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Aumer Shughoury, Ashay Bhatwadekar, Denis Jusufbegovic, Amir Hajrasouliha & Thomas A Ciulla. (2023) The evolving therapeutic landscape of diabetic retinopathy. Expert Opinion on Biological Therapy 0:0, pages 1-17.
Read now
Read now
David J Ramsey, Samuel J Poulin, Lauren C LaMonica, Gregory R Blaha, Fina C Barouch, Jeffrey Chang & Jeffrey L Marx. (2021) Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment Costs. Clinical Ophthalmology 15, pages 31-39.
Read now
Read now
Davis Bhagat, Breanne Kirby, Harit Bhatt, Rama Jager, Meena George & Veeral Sheth. (2020) Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema. Clinical Ophthalmology 14, pages 2975-2982.
Read now
Read now
Angela S. Li, Malini Veerappan, Vaishali Mittal & Diana V. Do. (2020) Anti-VEGF agents in the management of diabetic macular edema. Expert Review of Ophthalmology 15:5, pages 285-296.
Read now
Read now
Articles from other publishers (3)
Manuel Vargas-Peirano, Catalina Verdejo, Laura Vergara-Merino, Cristóbal Loézar, Martin Hoehmann & Javier Pérez-Bracchiglione. (2023) Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendations. British Journal of Ophthalmology 107:3, pages 313-319.
Crossref
Crossref
Benjamin K. Young, Min Hwang, Mark W. Johnson, Cagri G. Besirli & Thomas J. Wubben. (2022) A Caveat About Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy. American Journal of Ophthalmology 243, pages 77-82.
Crossref
Crossref
Benjamin K. Young, Mark W. Johnson & Thomas J. Wubben. (2021) Cost Analysis of Intravitreal Aflibercept vs Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy. JAMA Ophthalmology 139:7, pages 804.
Crossref
Crossref